Clinical Trials Browser

INDUSTRY × Has results × Androgen Receptor Antagonists × Clear all

NCT03899467 2024-02-12

The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Phase 2 Completed

61 enrolled 12 charts

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

NCT02987829 2021-04-23

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Phase 1/2 Completed

72 enrolled 19 charts

Adenocarcinoma